Erste Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $713K | Hold |
15,000
| – | – | 0.01% | 572 |
|
|
2025
Q1 | $598K | Hold |
15,000
| – | – | 0.01% | 418 |
|
|
2024
Q4 | $831K | Hold |
15,000
| – | – | 0.01% | 405 |
|
|
2024
Q3 | $741K | Hold |
15,000
| – | – | 0.01% | 403 |
|
|
2024
Q2 | $625K | Hold |
15,000
| – | – | 0.01% | 404 |
|
|
2024
Q1 | $753K | Buy |
+15,000
| New | +$753K | 0.01% | 393 |
|